CPTxGenetic Medicine company
CPTx is a genetic medicines company pioneering the development of in vivo genetic medicines built with single-stranded DNA. They develop programmable DNA nanofabrication designed to neutralize viruses by putting them into molecular cages, with a current focus on infectious diseases.
- Category
- Genetic Medicine
- Stage
- Series B
- Employees
- 43
- HQ
- Munich, Germany
- Founded
- 2021
- Funding
- $29M